The role of transcranial sonography in differentiation of dementia subtypes: an introduction of a new diagnostic method.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 09 03 2020
accepted: 02 07 2020
pubmed: 10 7 2020
medline: 15 5 2021
entrez: 10 7 2020
Statut: ppublish

Résumé

Transcranial sonography (TCS) is increasingly used for the diagnosis of neurodegenerative disorders. We assessed the role of third ventricle width (TVW), midbrain area (MA), and midbrain circumference (MC) by TCS for diagnosis and differentiation of dementia. A cross-sectional study was designed in 59 patients with dementia including 19 patients with Alzheimer's disease (AD), 10 Dementia with Lewy bodies (DLB), 23 Frontotemporal dementia (FTD) and 7 Vascular dementia (VaD), and 22 normal-cognition individuals. Both case and control groups were matched by age, sex, and educational level. The dementia patients were divided into two subgroups: cortical-dominant dementia (CDD) including AD and FTD; and subcortical-dominant dementia (SDD) including DLB and VaD. TCS was performed through a temporal window, in which the size of TVW and midbrain was measured by trans-thalamic and trans-mesencephalic planes, respectively. The mean TVW was 0.85 ± 0.3 cm and 0.66 ± 0.2 cm in dementia patients and the control group, respectively (p < 0.01). The MA/MC were smaller in dementia patients compared with the control group (p < 0.05 and p < 0.01). The TVW in CDD (p = 0.003) and SDD (p = 0.027), but only MA/MC in SDD (p < 0.05), was statistically different compared with the control group. The measurement of TVW and midbrain size by TCS can be used for diagnosis and differentiation of dementia. Patients with CDD and SDD have larger TVW than the control group, whereas patients with SDD have smaller midbrain sizes.

Identifiants

pubmed: 32643135
doi: 10.1007/s10072-020-04566-4
pii: 10.1007/s10072-020-04566-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

275-283

Références

(2014) The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis. Ont Health Technol Assess Ser 14(1):1–64
De Riva V, Galloni E, Marcon M, Di Dionisio L, Deluca C, Meligrana L et al (2013) Analysis of combined CSF biomarkers in AD diagnosis. Clin Lab 60(4):629–634
Pasi M, Poggesi A, Pantoni L (2011) The use of CT in dementia. Int Psychogeriatr 23(S2):S6–S12
doi: 10.1017/S1041610211000950
Davison CM, O'Brien JT (2014) A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review. International journal of geriatric psychiatry 29(6):551–561
doi: 10.1002/gps.4036
van der Flier WM, Scheltens P (2005) Epidemiology and risk factors of dementia. J Neurol Neurosurg Psychiatry 76(suppl 5):v2–v7
doi: 10.1136/jnnp.2005.082867
Walter U (2009) Imaging of the brain: where is transcranial sonography superior to magnet resonance imaging? Fortschr Neurol Psychiatr 77:S39–S41
doi: 10.1055/s-0028-1109606
Monaco D, Berg D, Thomas A, Di Stefano V, Barbone F, Vitale M, Ferrante C, Bonanni L, Di Nicola M, Garzarella T, Marchionno LP (2018) The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study. Neurol Sci 39(11):1887–1894
doi: 10.1007/s10072-018-3514-z
Mosavi A, Zamani B, Rouhani MJCD (2015) Midbrain area measurement by transcranial sonography for discrimination Parkinson disease from progressive supranuclear palsy (PSP): P16. 39
Walter U, Dressler D, Probst T, Wolters A, Abu-Mugheisib M, Wittstock M, Benecke R (2007) Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 64(11):1635–1640
doi: 10.1001/archneur.64.11.1635
Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. The Lancet Neurology. 7(11):1044–1055
doi: 10.1016/S1474-4422(08)70239-4
Svetel M, Mijajlović M, Tomić A, Kresojević N, Pekmezović T, Kostić VS (2012) Transcranial sonography in Wilson’s disease. Parkinsonism Relat Disord 18(3):234–238
doi: 10.1016/j.parkreldis.2011.10.007
Rohani M, Almasi M, Yousefpour F, Zamani B, Shahidi GJBG (2017) Echogenicity of lentiform nucleus in different types of idiopathic dystonia. 10:8–11
Walter U, Horowski S, Benecke R, Zettl UK (2007) Transcranial brain sonography findings related to neuropsychological impairment in multiple sclerosis. J Neurol 254(2):II49–II52
pubmed: 17503129
Berg D, Mäurer M, Warmuth-Metz M, Rieckmann P, Becker G (2000) The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis. Arch Neurol 57(9):1289–1292
doi: 10.1001/archneur.57.9.1289
Yaldizli Ö, Kastrup O, Obermann M, Esser S, Wilhelm H, Ley C, Forsting M, Maschke M (2006) Transcranial sonography of the third ventricle and cognitive dysfunction in HIV patients. J Neurol 253(9):1185–1188
doi: 10.1007/s00415-006-0191-2
Walter U, Dressler D, Wolters A, Wittstock M, Benecke R (2006) Sonographic discrimination of dementia with Lewy bodies and Parkinson’s disease with dementia. J Neurol 253(4):448–454
doi: 10.1007/s00415-005-0023-9
Wollenweber FA, Schomburg R, Probst M, Schneider V, Hiry T, Ochsenfeld A, Mueller M, Dillmann U, Fassbender K, Behnke S (2011) Width of the third ventricle assessed by transcranial sonography can monitor brain atrophy in a time-and cost-effective manner-results from a longitudinal study on 500 subjects. Psychiatry Res Neuroimaging 191(3):212–216
doi: 10.1016/j.pscychresns.2010.09.010
Lee JE, Park B, Song SK, Sohn YH, Park HJ, Lee PH (2010) A comparison of gray and white matter density in patients with Parkinson’s disease dementia and dementia with Lewy bodies using voxel-based morphometry. Mov Disord 25(1):28–34
doi: 10.1002/mds.22858
Lancu I, Olmer A (2006) The minimental state examination--an up-to-date review. Harefuah. 145(9):687–690 701
pubmed: 17078433
Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. The Lancet Neurology 6(8):734–746
doi: 10.1016/S1474-4422(07)70178-3
McKeith IG (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9(3 Supplement):417–423
doi: 10.3233/JAD-2006-9S347
Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu J, Garcia JA et al (1993) Vascular dementia diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 43(2):250
doi: 10.1212/WNL.43.2.250
Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EGP, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 134(9):2456–2477
doi: 10.1093/brain/awr179
Gorno-Tempini M, Hillis A, Weintraub S, Kertesz A, Mendez M, Cappa SE et al (2011) Classification of primary progressive aphasia and its variants. Neurology. 76(11):1006–1014
doi: 10.1212/WNL.0b013e31821103e6
Sahuquillo P, Tembl JI, Parkhutik V, Vázquez JF, Sastre I, Lago A (2013) The study of deep brain structures by transcranial duplex sonography and imaging resonance correlation. Ultrasound Med Biol 39(2):226–232
doi: 10.1016/j.ultrasmedbio.2012.09.008
Turner MA, Moran NF, Kopelman MD (2002) Subcortical dementia. Br J Psychiatry 180(2):148–151
doi: 10.1192/bjp.180.2.148
Suri S, Topiwala A, Mackay CE, Ebmeier KP, Filippini N (2014) Using structural and diffusion magnetic resonance imaging to differentiate the dementias. Current neurology and neuroscience reports 14(9):1–14
doi: 10.1007/s11910-014-0475-3
Zerfass R, Geiger-Kabisch C, Sattel H, Besthorn C, Hentschel F (1995) Brain atrophy in normal ageing and Alzheimer’s disease. Volumetric discrimination and clinical correlations. Br J Psychiatry 167(6):739–746
doi: 10.1192/bjp.167.6.739
Albert M, Naeser MA, Levine HL, Garvey AJ (1984) Ventricular size in patients with presenile dementia of the Alzheimer’s type. Arch Neurol 41(12):1258–1263
doi: 10.1001/archneur.1984.04050230040015
Barber R, Ballard C, McKeith I, Gholkar A, O’Brien J (2000) MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology. 54(6):1304–1309
doi: 10.1212/WNL.54.6.1304
Nakatsuka T, Imabayashi E, Matsuda H, Sakakibara R, Inaoka T, Terada H (2013) Discrimination of dementia with Lewy bodies from Alzheimer’s disease using voxel-based morphometry of white matter by statistical parametric mapping 8 plus diffeomorphic anatomic registration through exponentiated Lie algebra. Neuroradiology. 55(5):559–566
doi: 10.1007/s00234-013-1138-9
Leite AJB, van der Flier WM, van Straaten EC, Scheltens P, Barkhof F (2006) Infratentorial abnormalities in vascular dementia. Stroke. 37(1):105–110
doi: 10.1161/01.STR.0000196984.90718.8a
Sung Y-H, Park K-H, Lee Y-B, Park H-M, Shin DJ, Park J-S, Oh MS, Ma HI, Yu KH, Kang SY, Kim YJ, Lee BC (2009) Midbrain atrophy in subcortical ischemic vascular dementia. J Neurol 256(12):1997–2002
doi: 10.1007/s00415-009-5226-z
Pantel J, Schröder J, Essig M, Jauss M, Schneider G, Eysenbach K, von Kummer R, Baudendistel K, Schad LR, Knopp MV (1998) In vivo quantification of brain volumes in subcortical vascular dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord 9(6):309–316
doi: 10.1159/000017082
Cardenas VA, Boxer AL, Chao LL, Gorno-Tempini ML, Miller BL, Weiner MW, Studholme C (2007) Deformation-based morphometry reveals brain atrophy in frontotemporal dementia. Arch Neurol 64(6):873–877
doi: 10.1001/archneur.64.6.873
Yang Y, Schmitt HP (2001) Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Acta Neuropathol 101(3):256–270
doi: 10.1007/s004010000293
Sastre-Bataller I, Vázquez JF, Martínez-Torres I, Sahuquillo P, Rubio-Agustí I, Burguera JA, Ferrer JM, Valero C, Tembl JI (2013) Mesencephalic area measured by transcranial sonography in the differential diagnosis of parkinsonism. Parkinsonism Relat Disord 19(8):732–736
doi: 10.1016/j.parkreldis.2013.04.010
Kim JY, Kim ST, Jeon SH, Lee WY (2007) Midbrain transcranial sonography in Korean patients with Parkinson’s disease. Mov Disord 22(13):1922–1926
doi: 10.1002/mds.21628
Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM, and the Alzheimer's Disease Neuroimaging Initiative (2009) Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer’s disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp 30(9):2766–2788
doi: 10.1002/hbm.20708
Jack C, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ et al (1998) Rate of medial temporal lobe atrophy in typical aging and Alzheimer’s disease. Neurology. 51(4):993–999
doi: 10.1212/WNL.51.4.993
Hernández N, Escrivá A, Jordà J (2007) Study of the diameter of the third ventricle with transcranial sonography. Neurologia (Barcelona, Spain) 22(8):507–510
Seidel G, Gerriets T, Kaps M, Hutzelmann A (1995) Evaluation of the ventricular system in adults by transcranial duplex sonography. J Neuroimaging 5(2):105–108
doi: 10.1111/jon199552105

Auteurs

Mostafa Almasi-Dooghaee (M)

Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Valadi St, Valiasr St, Tehran, Iran. A_mostafa108@yahoo.com.

Mohammad Rohani (M)

Department of Neurology, Hazrat-e-Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran.

Atefeh Imani (A)

Faculty of Medicine, Islamic Azad University Tehran Medical Branch, Tehran, Iran.

Shabnam Nadjafi (S)

Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.

Babak Zamani (B)

Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Valadi St, Valiasr St, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH